Funding for this research was provided by:
Bristol-Myers Squibb (N/A)
Received: 11 February 2019
Accepted: 8 May 2019
First Online: 16 May 2019
Ethics approval and consent to participate
: The study protocol and consent were approved by the Cleveland Clinic Institutional Review Board (IRB # 17–586).
: No individual data or images are being published.
: M.O. reports researching funding, consulting fees, and speakers’ bureau honoraria from Bristol-Myers Squibb (BMS). L.S.W. reports speakers’ bureau honoraria from BMS. B.R. reports research funding and consulting fees from BMS.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.